Evidence map›Paper›PMID 23630357›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome.

Kevin Shenderov, Daniel L Barber, Katrin D Mayer-Barber, Sudagar S Gurcha, Dragana Jankovic, Carl G Feng, Sandy Oland, Sara Hieny, Pat Caspar, Sho Yamasaki and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Kevin ShenderovImmunobiology Section, Laboratory of Parasitic Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. shenderovk@niaid.nih.gov
Daniel L Barber
Katrin D Mayer-Barber
Sudagar S Gurcha
Dragana Jankovic
Carl G Feng
Sandy Oland
Sara Hieny
Pat Caspar
Sho Yamasaki
Xin Lin
Jenny P-Y Ting
Giorgio Trinchieri
Gurdyal S Besra
Vincenzo Cerundolo
Alan Sher
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USUniversity of Birmingham · GBFrederick National Laboratory for Cancer Research · USJohn Radcliffe Hospital · GBKyushu University · JPOxford University Hospitals NHS Trust · GBThe University of Texas MD Anderson Cancer Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Role of inflammation, innate resistance, and immunity in carcinogenesis.ZIABC010793 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TRINCHIERI, GIORGIO · 2009 to 2025
$16.8M
Innate Determinants of Microbial ImmunityZIAAI001044 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHER, ALAN · 2009 to 2022
$8.8M
Regulation of human dendritic cell activationZIABC011152 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TRINCHIERI, GIORGIO · 2009 to 2025
$8.6M
Cancer Research UK 11331Cancer Research UK C399/A2291Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001044Medical Research Council G1001023Medical Research Council G1001750NIAID NIH HHS Y99 AI999999Wellcome TrustWellcome Trust 081569/Z/06/ZWellcome Trust 084923/B/08/Z
6 · The paper itself

Abstract

Although adjuvants are critical vaccine components, their modes of action are poorly understood. In this study, we investigated the mechanisms by which the heat-killed mycobacteria in CFA promote Th17 CD4(+) T cell responses. We found that IL-17 secretion by CD4(+) T cells following CFA immunization requires MyD88 and IL-1β/IL-1R signaling. Through measurement of Ag-specific responses after adoptive transfer of OTII cells, we confirmed that MyD88-dependent signaling controls Th17 differentiation rather than simply production of IL-17. Additional experiments showed that CFA-induced Th17 differentiation involves IL-1β processing by the inflammasome, as mice lacking caspase-1, ASC, or NLRP3 exhibit partially defective responses after immunization. Biochemical fractionation studies further revealed that peptidoglycan is the major component of heat-killed mycobacteria responsible for inflammasome activation. By assaying Il1b transcripts in the injection site skin of CFA-immunized mice, we found that signaling through the adaptor molecule caspase activation and recruitment domain 9 (CARD9) plays a major role in triggering pro-IL-1β expression. Moreover, we demonstrated that recognition of the mycobacterial glycolipid trehalose dimycolate (cord factor) by the C-type lectin receptor mincle partially explains this CARD9 requirement. Importantly, purified peptidoglycan and cord factor administered in mineral oil synergized to recapitulate the Th17-promoting activity of CFA, and, as expected, this response was diminished in caspase-1- and CARD9-deficient mice. Taken together, these findings suggest a general strategy for the rational design of Th17-skewing adjuvants by combining agonists of the CARD9 pathway with inflammasome activators.

Indexed as

Adaptor Proteins, Signal TransducingAdjuvants, ImmunologicAnimalsCARD Signaling Adaptor ProteinsCell DifferentiationCord FactorsInflammasomesInterleukin-1betaLectins, C-TypeMembrane ProteinsMiceMice, KnockoutMycobacteriumMyeloid Differentiation Factor 88PeptidoglycanReceptors, Interleukin-1Adaptor Proteins, Signal TransducingAdjuvants, ImmunologicCard9 protein, mouseCARD Signaling Adaptor ProteinsClecsf8 protein, mouseCord FactorsInflammasomesInterleukin-1betaLectins, C-TypeMembrane ProteinsMyeloid Differentiation Factor 88PeptidoglycanReceptors, Interleukin-1Receptors, Interleukin-18Toll-Like Receptors

Identifiers

PMID23630357
PMCPMC3719989
OpenAlexW2105243809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.